Skip to content

Lentiviral viral vector CDMO

17 listings from 15 suppliers · 1 Japanese maker

Japanese name: レンチウイルス/ウイルスベクター製造受託(GMPベクターCDMO)

Lentiviral vector CDMOs manufacture viral vectors under GMP for cell and gene therapies such as CAR-T, using transient transfection or stable packaging cell lines. Buyers compare whether the process runs in suspension or adherent culture, the scale the CDMO can reach, and the time needed to reach GMP production against the development plan. Listed here are global CDMOs, platform vendors and Japanese suppliers.

Platform-type and specialist vendors
ProductMakerWhere to buy in Japan
ProntoLVV™ platformAGC BiologicsNot yet confirmed
LentiSure™ manufacturing platformYposkesiNot yet confirmed
Lentiviral vector CDMO servicesVIVEbiotechNot yet confirmed
Lenti.RiGHT® packaging / producer cell linesProBioGenNot yet confirmed
Cytegrity™ producer cell lines / GMP lentivirus manufacturingGenezenNot yet confirmed
LVV Curator® platformAndelyn BiosciencesNot yet confirmed
GMP Lentiviral Vector PlatformMiltenyi BioindustryNot yet confirmed
GMP lentiviral vector (LVV) manufacturingGenScript ProBioNot yet confirmed

“Where to buy in Japan” shows only sales relationships we have confirmed on the company’s or the distributor’s own website. “Not yet confirmed” means we have not checked yet, not that the product is unavailable in Japan. Product names link to the maker’s own page.